brain health in youth with normal weight, overweight and obesity at risk for type 2 diabetes (t2d)

Conditions: Type2 Diabetes; Type 2 Diabetes Mellitus in Obese; Dysglycemia; Microvascular Complications; Brain Structure; Obesity, Childhood; Diabetes in Adolescence; Inflammation; Insulin Resistance; Overweight, Childhood; Cognitive Decline

Summary: investigators propose to study youth across the spectrum of body mass index (bmi) and dysglycemia. this approach will allow investigators to disentangle the relationship of key features of type 2 diabetes (t2d) risk (e.g. obesity) with intermediary physiologic changes (e.g. insulin resistance, inflammation, β-cell dysfunction and dysglycemia) that pose a risk for the brain. investigators will determine which of these factors are most associated with differences in brain structure and function among groups, over time, and how these effects differ from normal neurodevelopment.

investigators will study three groups of pubertal youth, ages 12-17 yrs old (n=31 each): a group with normal weight and normal glucose tolerance (nw-ngt), a group with overweight/obesity and normal glucose tolerance (o-ngt), and a group with overweight/obesity and dysglycemia (o-dg). groups will be comparable in age, sex, race/ethnicity, and socio-economic status (ses). brain structure and function will be examined in all groups using magnetic resonance imaging (mri) and cognitive tests at study entry (time 1/baseline), and after 21 months (time 2), focusing on a limited number of key outcome variables known to be consistently impaired in obesity or t2d. targeted mri measures will be regional volumes (e.g. hippocampus), neuroinflammation via restricted ratio from diffusion basis spectrum imaging (dbsi); hippocampus and white matter tracts), whole-brain cerebral blood flow via arterial spin labeling (asl). targeted cognitive measures will be delayed memory, processing speed, and executive function. the ultimate goal of this study is to determine how metabolic factors during neurodevelopment set the stage for the potentially profound, long-term impact of t2d on the brain and its functions. given that the disease occurs at a time when brains are undergoing dramatic developmental processes, the aggressive nature of youth-onset t2d progression and complications in other organ systems, these results may provide guidance and justification for longer follow-up, interventional and/or mechanistic studies, and have important clinical implications.

Eligibility criteria:
inclusion criteria: * 12-17 yrs. old at visit 1, 12-19 yrs. old at visit 2, tanner ii or above (determined through an exam by a pediatric endocrinologist or certified nurse practitioner trained in pediatric endocrinology), otherwise healthy except for obesity, \<450 lbs. (due to mri scanner limits), able and willing to lie flat within the mri scanner and do cognitive testing, fluent in english. exclusion criteria: * syndromic obesity, history of bariatric surgery, insulin treatment (metformin allowed if \ 10 min loss of consciousness), significant psychiatric disorders (e.g., schizophrenia, bipolar disorder, current major depression), taking psychoactive medications (e.g., antipsychotics) that would interfere with testing or reporting illegal drug use. self-reported smoking and alcohol use and length of time with obesity will be assessed by history (although these measures may not be fully reliable).

Keywords: brain, health, youth, type 2 diabetes mellitus, overweight, obesity